Asparagine-linked glycosylation 1-like 3, pseudogene (ALG1L3P)

Asparagine-linked glycosylation 1-like 3, pseudogene (ALG1L3P) is classified as a pseudogene related to the ALG1 gene family in Homo sapiens. Pseudogenes are segments of DNA that resemble known genes but are not translated into functional proteins, often due to mutations or loss of regulatory elements. ALG1L3P does not encode an active beta-1,4-mannosyltransferase enzyme and lacks known therapeutic, diagnostic, or drug-targeting relevance. Pseudogenes in general can have non-coding RNA-mediated regulatory roles (such as acting as competing endogenous RNA “decoys” for microRNAs), but there is no evidence in current literature that ALG1L3P exhibits such regulatory function. It is not a protein-coding gene, receptor, enzyme, transporter, nor otherwise considered a "target" in the pharmacological or clinical sense. Notes on nomenclature and correctness: - ALG1L3P is sometimes confused with the parent functional gene, ALG1 (asparagine-linked glycosylation 1, chitobiosyldiphosphodolichol beta-mannosyltransferase), which encodes a key enzyme involved in N-linked glycosylation and is associated with congenital disorders when mutated. However, ALG1L3P is explicitly annotated as a pseudogene, meaning it does not produce a functional protein. - As such, it is not a legitimate therapeutic target, and listing ALG1L3P as a "receptor" or functional enzyme would be incorrect. Summary: ALG1L3P is a non-functional pseudogene related to the glycosylation process, with no known direct biological, pathological, or therapeutic roles. It is not a protein, receptor, or functional gene and should not be considered a therapeutic target.

Other names

asparagine-linked glycosylation 1 homolog pseudogeneasparagine-linked glycosylation 1-like pseudogenebeta-1,4-mannosyltransferase pseudogene